Optiscan Intends to pursue De Novo Pathway for InVivage
Filed with ASX · · 2 pages · English
Optiscan Imaging Limited on 6ix
Story so far
Earlier from Optiscan Imaging
- OIL Appendix 4D and 31 December 2022 Half-year report
- Optiscan partners with Prolucid to develop AI Algorithms
- OIL December 2022 Quarterly Report and Appendix 4C
- Optiscan Managing Director 2022 AGM Presentation
- OIL September 2022 Quarterly Report and Appendix 4C
Later from Optiscan Imaging
- Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
- OIL March 2023 Quarterly Report and Appendix 4C
- Trading Halt
- Optiscan Entitlement Issue Prospectus
- Optiscan Launches Entitlement Offer to Raise $16.7M
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging